Carotid Intima-Media Thickness and the Risk of Sudden Cardiac Death: The ARIC Study and the CHS.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
20 10 2020
Historique:
pubmed: 26 9 2020
medline: 16 3 2021
entrez: 25 9 2020
Statut: ppublish

Résumé

Background Sudden cardiac death (SCD) is associated with severe coronary heart disease in the great majority of cases. Whether carotid intima-media thickness (C-IMT), a known surrogate marker of subclinical atherosclerosis, is associated with risk of SCD in a general population remains unknown. The objective of this study was to investigate the association between C-IMT and risk of SCD. Methods and Results We examined a total of 20 862 participants: 15 307 participants of the ARIC (Atherosclerosis Risk in Communities) study and 5555 participants of the CHS (Cardiovascular Health Study). C-IMT and common carotid artery intima-media thickness was measured at baseline by ultrasound. Presence of plaque was judged by trained readers. Over a median of 23.5 years of follow-up, 569 participants had SCD (1.81 cases per 1000 person-years) in the ARIC study. Mean C-IMT and common carotid artery intima-media thickness were associated with risk of SCD after adjustment for traditional risk factors and time-varying adjustors: hazard ratios (HRs) with 95% CIs for fourth versus first quartile were 1.64 (1.15-2.63) and 1.49 (1.05-2.11), respectively. In CHS, 302 participants developed SCD (4.64 cases per 1000 person-years) over 13.1 years. Maximum C-IMT was associated with risk of SCD after adjustment: HR (95% CI) for fourth versus first quartile was 1.75 (1.22-2.51). Presence of plaque was associated with 35% increased risk of SCD: HR (95% CI) of 1.37 (1.13-1.67) in the ARIC study and 1.32 (1.04-1.68) in CHS. Conclusions C-IMT was associated with risk of SCD in 2 biracial community-based cohorts. C-IMT may be used as a marker of SCD risk and potentially to initiate early therapeutic interventions to mitigate the risk.

Identifiants

pubmed: 32975158
doi: 10.1161/JAHA.120.016981
pmc: PMC7792412
doi:

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e016981

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201100008C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85080
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG023629
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85082
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC55222
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85086
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100012C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100009C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85081
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100010C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL080295
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100007C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201200036C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100011C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL130114
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85079
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85083
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100006C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268200800007C
Pays : United States

Références

Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
Stroke. 2011 Nov;42(11):3075-9
pubmed: 21940954
Ann Epidemiol. 1991 Feb;1(3):263-76
pubmed: 1669507
Europace. 2006 Sep;8(9):746-837
pubmed: 16935866
Am Heart J. 2010 Jan;159(1):33-9
pubmed: 20102864
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
Am J Cardiol. 2008 Apr 1;101(7):1016-22
pubmed: 18359324
Biomed Pharmacother. 2005 Oct;59 Suppl 1:S49-53
pubmed: 16275507
Circ Heart Fail. 2008 Nov;1(4):242-8
pubmed: 19808298
Eur Heart J. 2017 Jun 7;38(22):1717-1727
pubmed: 27252448
J Am Coll Cardiol. 2012 Dec 25;60(25):2674-82
pubmed: 23177296
Ann Intern Med. 2001 Jan 2;134(1):12-20
pubmed: 11187415
Echocardiography. 2009 Aug;26(7):785-800
pubmed: 19552673
Circulation. 2006 Apr 18;113(15):1842-8
pubmed: 16618831
J Am Heart Assoc. 2020 Oct 20;9(19):e016981
pubmed: 32975158
Eur Heart J. 2012 Jan;33(2):183-90
pubmed: 21666250
Ann Epidemiol. 1995 Jul;5(4):278-85
pubmed: 8520709
Circulation. 2014 Jan 28;129(4):516-26
pubmed: 24470473
Ann Epidemiol. 1995 Jul;5(4):270-7
pubmed: 8520708
J Am Coll Cardiol. 2010 Apr 13;55(15):1600-7
pubmed: 20378078
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
J Am Coll Cardiol. 2004 Jun 16;43(12):2236-41
pubmed: 15193686
Circulation. 2002 Jun 4;105(22):2595-9
pubmed: 12045163
Heart. 2017 Mar;103(5):383-389
pubmed: 27604814
Stroke. 2012 Jan;43(1):103-8
pubmed: 22033999
Eur Heart J. 2000 Jun;21(11):919-26
pubmed: 10806016
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Trends Cardiovasc Med. 2016 Jan;26(1):23-33
pubmed: 25957808
Am J Epidemiol. 1997 Sep 15;146(6):483-94
pubmed: 9290509
J Am Coll Cardiol. 2010 Oct 26;56(18):1476-83
pubmed: 20951323
Stroke. 1994 Dec;25(12):2377-83
pubmed: 7974576
Heart Rhythm. 2013 Oct;10(10):1425-32
pubmed: 23906927

Auteurs

Takeki Suzuki (T)

Krannert Institute of Cardiology Department of Medicine Indiana University Indianapolis IN.

Wanmei Wang (W)

Department of Biostatistics University of Mississippi Medical Center Jackson MS.

Anthony Wilsdon (A)

Department of Biostatistics University of Washington Seattle WA.

Kenneth R Butler (KR)

Department of Medicine University of Mississippi Medical Center Jackson MS.

Selcuk Adabag (S)

Veterans Affairs Medical Center Minneapolis MN.

Michael E Griswold (ME)

Department of Data Science University of Mississippi Medical Center Jackson MS.

Vijay Nambi (V)

Michael E. DeBakey Veterans Affairs Hospital Baylor College of Medicine Houston TX.

Wayne Rosamond (W)

Department of Epidemiology Gillings School of Global Public Health University of North Carolina Chapel Hill NC.

Nona Sotoodehnia (N)

Cardiovascular Health Research Unit University of Washington Seattle WA.

Thomas H Mosley (TH)

Department of Medicine University of Mississippi Medical Center Jackson MS.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH